| RS1412883921 |
RDX
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 24, Autosomal recessive nonsyndromic hearing loss 24 |
| RS141288548 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS1412892301 |
F8
|
Health Risk |
Likely pathogenic |
F8-related disorder, F8-related disorder |
| RS1412895796 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS1412910699 |
CHST6
|
Health Risk |
Pathogenic |
Macular corneal dystrophy, Macular corneal dystrophy |
| RS1412913967 |
FBXO11
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1412914051 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS141291583 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Xanthinuria type II, XDH-related disorder |
| RS141292792 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS141292909 |
SRPX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Rolandic epilepsy, intellectual disability |
| RS141293060 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS141293178 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperthyroidism due to mutations in TSH receptor, Hypothyroidism due to TSH receptor mutations |
| RS141293401 |
GIPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1412940366 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS141294063 |
SLC17A8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141295085 |
SELENON
|
Health Risk |
Conflicting classifications of pathogenicity |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS141295561 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 12, Naxos disease |
| RS141295770 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS1412967226 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1412973951 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS141297873 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS141298287 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS141298709 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS141298868 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS141299250 |
HCRTR2
|
Health Risk |
Conflicting classifications of pathogenicity |
HCRTR2-related disorder, HCRTR2-related disorder |
| RS1413000730 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS141300510 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS141301073 |
PRKCSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic liver disease 1, Polycystic liver disease 1 |
| RS1413017181 |
TYR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 1B, Oculocutaneous albinism type 1A |
| RS141301945 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141302945 |
CTNND2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS141303335 |
COQ4
|
Health Risk |
Likely pathogenic |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome |
| RS141303532 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
FLCN-related disorder, FLCN-related disorder |
| RS141304350 |
TTC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Retinitis pigmentosa |
| RS141304474 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS141304487 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Anemia |
| RS141304623 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS141305257 |
CLN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS1413052728 |
FRMD7
|
Health Risk |
Likely pathogenic |
— |
| RS141305290 |
INPPL1
|
Health Risk |
Conflicting classifications of pathogenicity |
INPPL1-related disorder, Inborn genetic diseases |
| RS141305506 |
OPN1SW
|
Health Risk |
Conflicting classifications of pathogenicity |
Blue color blindness, Blue color blindness |
| RS1413055215 |
SLC30A7
|
Health Risk |
Likely pathogenic |
Ziegler-Huang syndrome, Decreased testicular size |
| RS141305721 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1413063599 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1413065373 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS141306917 |
TG
|
Health Risk |
Pathogenic |
Autoimmune thyroid disease, susceptibility to |
| RS141307064 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1413085360 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1413085852 |
PNKP
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS141308774 |
RAC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutrophil immunodeficiency syndrome, Inborn genetic diseases |
| RS1413091136 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS141309351 |
POMC
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to pro-opiomelanocortin deficiency, Inherited obesity |
| RS141309818 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141310259 |
RASA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141310425 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS141311765 |
MPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1413121429 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Pendred syndrome |
| RS141312224 |
UROD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141314418 |
GSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Finnish type amyloidosis |
| RS141314684 |
CASQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS141314828 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Xanthinuria type II, Inborn genetic diseases |
| RS141315518 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS141315681 |
PDE4DIP
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS141315771 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome, Perrault syndrome |
| RS141315921 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS141316327 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Lethal congenital glycogen storage disease of heart |
| RS1413163992 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1413169361 |
LFNG
|
Health Risk |
Likely pathogenic |
Spondylocostal dysostosis 3, autosomal recessive |
| RS141317462 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS1413175771 |
ABCA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS1413177521 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1413181007 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS141318501 |
CACNA2D4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal cone dystrophy 4, Retinal cone dystrophy 4 |
| RS141318533 |
FSIP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spermatogenic failure 34, FSIP2-related disorder |
| RS1413186293 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1413197098 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS141319759 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Imerslund-Grasbeck syndrome type 1 |
| RS141319800 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS141321114 |
CENPE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141321409 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Inborn genetic diseases |
| RS1413214135 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS141321678 |
CFHR5
|
Health Risk |
Conflicting classifications of pathogenicity |
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Atypical hemolytic-uremic syndrome |
| RS1413222465 |
GDAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS1413238389 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS141324034 |
AMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS141324048 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
HMCN1-related disorder, HMCN1-related disorder |
| RS1413243663 |
BMPR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1413244355 |
FASLG
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Lung cancer |
| RS141324814 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS141324828 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1413259742 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1413266657 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1413274209 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile hypophosphatasia, Adult hypophosphatasia |
| RS141327514 |
CCBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS141327522 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS141328044 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS141328606 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1413289687 |
CPAP
|
Health Risk |
Pathogenic |
— |
| RS141329633 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS141330687 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4B2 |